Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs

Here we report the results of a large-scale pre-license safety study in which two serials of VANGUARD®crLyme, a vaccine for canine Lyme disease, were tested in its target population (dogs) under the conditions of its intended use. Six-hundred and twenty dogs, from three distinct geographic regions o...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconi, Richard T., Honsberger, Nicole, Teresa Winkler, M., Sobell, Nikki, King, Vickie L., Wappel, Sharon, Hoevers, Jacquelien, Xu, Zach, Millership, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733143/
https://www.ncbi.nlm.nih.gov/pubmed/33336186
http://dx.doi.org/10.1016/j.jvacx.2020.100080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733143/
https://www.ncbi.nlm.nih.gov/pubmed/33336186
http://dx.doi.org/10.1016/j.jvacx.2020.100080

Ejemplares similares